149 related articles for article (PubMed ID: 35043584)
21. Autophagy-based survival prognosis in human colorectal carcinoma.
Yang M; Zhao H; Guo L; Zhang Q; Zhao L; Bai S; Zhang M; Xu S; Wang F; Wang X; Zhao B
Oncotarget; 2015 Mar; 6(9):7084-103. PubMed ID: 25762626
[TBL] [Abstract][Full Text] [Related]
22. ATAD2 overexpression is associated with progression and prognosis in colorectal cancer.
Hou M; Huang R; Song Y; Feng D; Jiang Y; Liu M
Jpn J Clin Oncol; 2016 Mar; 46(3):222-7. PubMed ID: 26819280
[TBL] [Abstract][Full Text] [Related]
23. ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer.
Zhou JK; Zheng YZ; Liu XS; Gou Q; Ma R; Guo CL; Croce CM; Liu L; Peng Y
Oncotarget; 2017 May; 8(20):32864-32872. PubMed ID: 28427197
[TBL] [Abstract][Full Text] [Related]
24. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
[TBL] [Abstract][Full Text] [Related]
25. DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.
Lin L; Piao J; Gao W; Piao Y; Jin G; Ma Y; Li J; Lin Z
BMC Cancer; 2013 Jul; 13():366. PubMed ID: 23902796
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
[TBL] [Abstract][Full Text] [Related]
27. NRF2 metagene signature is a novel prognostic biomarker in colorectal cancer.
O'Cathail SM; Wu CH; Lewis A; Holmes C; Hawkins MA; Maughan T
Cancer Genet; 2020 Oct; 248-249():1-10. PubMed ID: 32871287
[TBL] [Abstract][Full Text] [Related]
28. A novel molecular marker of prognosis in colorectal cancer: Vasohibin-1.
Yan Y; Shen Z; Ye Y; Jiang K; Zhang H; Shen C; Mustonen H; Puolakkainen P; Wang S
Med Oncol; 2014 Feb; 31(2):816. PubMed ID: 24366689
[TBL] [Abstract][Full Text] [Related]
29. Expression of ITGB1 predicts prognosis in colorectal cancer: a large prospective study based on tissue microarray.
Liu QZ; Gao XH; Chang WJ; Gong HF; Fu CG; Zhang W; Cao GW
Int J Clin Exp Pathol; 2015; 8(10):12802-10. PubMed ID: 26722470
[TBL] [Abstract][Full Text] [Related]
30. Development of a 15-gene signature for predicting prognosis in advanced colorectal cancer.
Wang X; Li T
Bioengineered; 2020 Dec; 11(1):165-174. PubMed ID: 32036725
[TBL] [Abstract][Full Text] [Related]
31. S100A4 over-expression underlies lymph node metastasis and poor prognosis in colorectal cancer.
Huang LY; Xu Y; Cai GX; Guan ZQ; Sheng WQ; Lu HF; Xie LQ; Lu HJ; Cai SJ
World J Gastroenterol; 2011 Jan; 17(1):69-78. PubMed ID: 21218086
[TBL] [Abstract][Full Text] [Related]
32. Identification of a five-gene signature with prognostic value in colorectal cancer.
Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
[TBL] [Abstract][Full Text] [Related]
33. Twist2 is a valuable prognostic biomarker for colorectal cancer.
Yu H; Jin GZ; Liu K; Dong H; Yu H; Duan JC; Li Z; Dong W; Cong WM; Yang JH
World J Gastroenterol; 2013 Apr; 19(15):2404-11. PubMed ID: 23613636
[TBL] [Abstract][Full Text] [Related]
34. Aberrant expression of sphingosine-1-phosphate receptor 1 correlates with metachronous liver metastasis and poor prognosis in colorectal cancer.
Lin Q; Wei Y; Zhong Y; Zhu D; Ren L; Xu P; Zheng P; Feng Q; Ji M; Lv M; Liang C; Xu J
Tumour Biol; 2014 Oct; 35(10):9743-50. PubMed ID: 24972972
[TBL] [Abstract][Full Text] [Related]
35. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
36. Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
Karamitopoulou E; Zlobec I; Koumarianou A; Patsouris ES; Peros G; Lugli A
Cancer; 2010 Oct; 116(19):4474-86. PubMed ID: 20572035
[TBL] [Abstract][Full Text] [Related]
37. MAP17 Expression in Colorectal Cancer Is a Prognostic Factor for Disease Recurrence and Dismal Prognosis Already in Early Stage Disease.
Tampakis A; Tampaki EC; Nonni A; Kontos M; Tsourouflis G; Posabella A; Fourie L; Bolli M; Kouraklis G; von Flüe M; Felekouras E; Nikiteas N
Oncology; 2021; 99(7):471-482. PubMed ID: 33853080
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Correlation Between MFG-E8 Expression Level and Colorectal Cancer.
Jia M; Yao H; Chen C; Wang Y; Wang H; Cui T; Zhu J
Arch Med Res; 2017 Apr; 48(3):270-275. PubMed ID: 28923329
[TBL] [Abstract][Full Text] [Related]
39. Prognostic biomarkers in colorectal cancer: where do we stand?
Sagaert X
Virchows Arch; 2014 Mar; 464(3):379-91. PubMed ID: 24487787
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of 3-CpG methylation prognostic signature based on different survival indicators for colorectal cancer.
Huang H; Zhang L; Fu J; Tian T; Liu X; Liu Y; Sun H; Li D; Zhu L; Xu J; Zheng T; Jia C; Zhao Y
Mol Carcinog; 2021 Jun; 60(6):403-412. PubMed ID: 33826760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]